Global Cell Therapy Technologies Market Size study, by Product, by Cell Type, by Cell Process, by End User, and Regional Forecasts 2022-2032

Description

Global Cell Therapy Technologies Market is valued approximately at USD 4.21 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 13.38% over the forecast period 2024-2032. Cell therapy technologies encompass a range of advanced techniques and tools designed to support the development, manufacturing, and application of cell-based therapies. These technologies include cell isolation and purification systems, cell culture media and reagents, bioreactors, cryopreservation methods, and cell analysis tools. They are essential in the production of therapies involving stem cells, immune cells, and other cell types used to treat various diseases, including cancer, autoimmune disorders, and genetic conditions. Advances in cell therapy technologies aim to improve the efficiency, scalability, and safety of cell therapies, making them more accessible and effective for patients. These innovations are driving the growth of personalized medicine, offering new hope for treatments that are tailored to individual patient needs.

The Global Cell Therapy Technologies Market is driven by rising incidence of chronic and infectious diseases has underscored the importance of advanced cell therapy technologies, propelling market growth. The comprehensive research encompasses an exhaustive examination of industry trends, meticulous pricing analysis, patent scrutiny, insights derived from conferences and webinars, identification of key stakeholders, and a nuanced understanding of market purchasing dynamics. Increasing government investments in cell-based research, coupled with heightened private funding, have been instrumental in driving market growth. Furthermore, the strategic emphasis on the launch of novel products by key market players has significantly contributed to the market's expansion. Moreover, the market is poised to benefit from increased focus on personalized medicine, presenting substantial growth opportunities. However, the industry faces challenges in meeting regulatory guidelines and maintaining stringent quality standards in cell biology research, which incur high costs. This poses a challenge for institutes and small-scale companies with limited budgets, as they may struggle to afford expensive research products.

The key regions considered for the Global Cell Therapy Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America accounted for the largest share of the market, attributed to several key factors such as the presence of leading market players and increased government investments in cell-based research. The region's robust infrastructure and supportive regulatory environment further bolster its dominance in the cell therapy technologies market. Furthermore, the market in Asia Pacific is anticipated to develop at the fastest rate over the forecast period 2024-2032.

Major market player included in this report are:

Sartorius AG
FUJIFILM Irvine Scientific, Inc.
Lonza Group AG
Becton Dickinson and Company
GE Healthcare
Terumo BCT
Avantor Inc.
Bio-Techne Corporation
Corning Incorporated
BPS Bioscience, Inc.
Novartis AG
Kite Pharma
Thermo Fisher Scientific, Inc.
Merck KGaA
Danaher Corporation

The detailed segments and sub-segment of the market are explained below:

By Product

Media, Sera, Reagents
Cell Engineering products
Cell Culture Vessels
Cell therapy Equipment
System & Software
Other Products

By Cell Type

T-Cells
Stem Cells
Other Cells

By Cell Process

Cell Processing
Cell Preservation, Distribution, and Handling
Process Monitoring and Quality Control

By End User

Biopharmaceutical & Biotechnology companies
CRO's & CMO's
Research Institutes & Cell Banks

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Cell Therapy Technologies Market Executive Summary

1.1. Global Cell Therapy Technologies Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Cell Type
- 1.3.3. By Cell Process
- 1.3.4. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Cell Therapy Technologies Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Cell Therapy Technologies Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising incidence of chronic and infectious diseases
- 3.1.2. Increasing government investments in cell-based research
- 3.1.3. Emphasis on novel product launches by key market players
3.2. Market Challenges
- 3.2.1. High costs associated with maintaining quality standards
- 3.2.2. Regulatory compliance issues
3.3. Market Opportunities
- 3.3.1. Increased focus on personalized medicine
- 3.3.2. Technological advancements in cell therapy
- 3.3.3. Expansion into emerging markets

Chapter 4. Global Cell Therapy Technologies Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Cell Therapy Technologies Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Cell Therapy Technologies Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Media, Sera, Reagents
- 5.2.2. Cell Engineering Products
- 5.2.3. Cell Culture Vessels
- 5.2.4. Cell Therapy Equipment
- 5.2.5. Systems & Software
- 5.2.6. Other Products

Chapter 6. Global Cell Therapy Technologies Market Size & Forecasts by Cell Type 2022-2032

6.1. Segment Dashboard
6.2. Global Cell Therapy Technologies Market: Cell Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. T-Cells
- 6.2.2. Stem Cells
- 6.2.3. Other Cells

Chapter 7. Global Cell Therapy Technologies Market Size & Forecasts by Cell Process 2022-2032

7.1. Segment Dashboard
7.2. Global Cell Therapy Technologies Market: Cell Process Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. Cell Processing
- 7.2.2. Cell Preservation, Distribution, and Handling
- 7.2.3. Process Monitoring and Quality Control

Chapter 8. Global Cell Therapy Technologies Market Size & Forecasts by End User 2022-2032

8.1. Segment Dashboard
8.2. Global Cell Therapy Technologies Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Biopharmaceutical & Biotechnology Companies
- 8.2.2. CRO's & CMO's
- 8.2.3. Research Institutes & Cell Banks

Chapter 9. Global Cell Therapy Technologies Market Size & Forecasts by Region 2022-2032

9.1. North America Cell Therapy Technologies Market
- 9.1.1. U.S. Cell Therapy Technologies Market
  - 9.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 9.1.1.2. Cell Type breakdown size & forecasts, 2022-2032
  - 9.1.1.3. Cell Process breakdown size & forecasts, 2022-2032
  - 9.1.1.4. End User breakdown size & forecasts, 2022-2032
- 9.1.2. Canada Cell Therapy Technologies Market
9.2. Europe Cell Therapy Technologies Market
- 9.2.1. U.K. Cell Therapy Technologies Market
- 9.2.2. Germany Cell Therapy Technologies Market
- 9.2.3. France Cell Therapy Technologies Market
- 9.2.4. Spain Cell Therapy Technologies Market
- 9.2.5. Italy Cell Therapy Technologies Market
- 9.2.6. Rest of Europe Cell Therapy Technologies Market
9.3. Asia-Pacific Cell Therapy Technologies Market
- 9.3.1. China Cell Therapy Technologies Market
- 9.3.2. India Cell Therapy Technologies Market
- 9.3.3. Japan Cell Therapy Technologies Market
- 9.3.4. Australia Cell Therapy Technologies Market
- 9.3.5. South Korea Cell Therapy Technologies Market
- 9.3.6. Rest of Asia Pacific Cell Therapy Technologies Market
9.4. Latin America Cell Therapy Technologies Market
- 9.4.1. Brazil Cell Therapy Technologies Market
- 9.4.2. Mexico Cell Therapy Technologies Market
- 9.4.3. Rest of Latin America Cell Therapy Technologies Market
9.5. Middle East & Africa Cell Therapy Technologies Market
- 9.5.1. Saudi Arabia Cell Therapy Technologies Market
- 9.5.2. South Africa Cell Therapy Technologies Market
- 9.5.3. Rest of Middle East & Africa Cell Therapy Technologies Market

Chapter 10. Competitive Intelligence

10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
- 10.3.1. Sartorius AG
  - 10.3.1.1. Key Information
  - 10.3.1.2. Overview
  - 10.3.1.3. Financial (Subject to Data Availability)
  - 10.3.1.4. Product Summary
  - 10.3.1.5. Market Strategies
- 10.3.2. FUJIFILM Irvine Scientific, Inc.
- 10.3.3. Lonza Group AG
- 10.3.4. Becton Dickinson and Company
- 10.3.5. GE Healthcare
- 10.3.6. Terumo BCT
- 10.3.7. Avantor Inc.
- 10.3.8. Bio-Techne Corporation
- 10.3.9. Corning Incorporated
- 10.3.10. BPS Bioscience, Inc.
- 10.3.11. Novartis AG
- 10.3.12. Kite Pharma
- 10.3.13. Thermo Fisher Scientific, Inc.
- 10.3.14. Merck KGaA
- 10.3.15. Danaher Corporation

Chapter 11. Research Process

11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
11.2. Research Attributes